Nektar(NKTR) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Nektar Therapeutics Reports Second Quarter 2024 Financial Results SAN FRANCISCO, August 8, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the second quarter ended June 30, 2024. Cash and investments in marketable securities at June 30, 2024 were $290.6 million as compared to $329.4 million at December 31, 2023. Nektar's cash and marketable securities are expected to support strategic development activities and operations into the third quarter of 20 ...